Funding for this research was provided by:
European and Developing Countries Clinical Trials Partnership (IP.2007.33011.003)
Instituto de Salud Carlos III (A107/90015)
Received: 18 January 2019
Accepted: 1 April 2019
First Online: 10 May 2019
Ethics approval and consent to participate
: This secondary analysis was approved by the National University of Singapore Institutional Review Board (S-17-017E). The trial protocol was approved by ethics committees in all participating countries and by the research ethics committee of the University College London, UK.Informed consent was obtained from all individual participants or their caregivers, in the case of participants less than 18 years of age, included in the study. Patients below 18 years of age also gave assent.
: Not applicable.
: All authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.